Skip to main content
SpringerLink
Log in

Dystonic Camptocormia: Clinical Presentation, Diagnosis, and Treatment Results

  • Published:
Human Physiology Aims and scope Submit manuscript

Abstract

This study was aimed at assessing clinical features of camptocormia as one of the dystonia symptoms and evaluating the efficacy of various treatments for this condition. The study involved 39 patients with dystonia and camptocormia symptoms. We analyzed the clinical features of dystonic camptocormia and evaluated the results of pharmacotherapy and botulinum therapy as well as neuromodulation methods, namely transcranial magnetic stimulation and deep brain stimulation. A phased and integrated approach was shown to be required for managing patients with camptocormia caused by dystonic hyperkinesis. Local botulinum toxin injections and deep brain stimulation are the most effective treatments. More extensive use of low-frequency transcranial magnetic stimulation may be advisable for everyday practical use in patients with dystonic camptocormia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Illarioshkin, S.N., Markova, E.D., Miklina, N.I., and Ivanova-Smolenskaya, I.A., Molecular genetics of the heredited dystonic syndromes, Zh. Nevropatol. Psikhiatr. im. S.S. Korsakova, 2000, vol. 8, pp. 60–66.

    Google Scholar 

  2. Kovalenko, A.P., The use of botulinum therapy for the therapy of camptocormia in patients with Parkinson’s disease: clinical case, in Bolezn’ Parkinsona i rasstroistvo dvizhenii. Rukovodstvo dlya vrachei (Parkinson’s Disease and Movement Disorders: Manual for Physicians), Illarioshkin, S.N. and Levin, Eds., Moscow: Sovero Press, 2014, pp. 198–200.

    Google Scholar 

  3. Ruskovodstvo pol’zovatelya “Stabilan-01.” Programmno-metodicheskoe obespechenie komp’yuternogo stabilometricheskogo kompleksa “StabMed 2.0” (User’s Manual “Stabilan-01.” Software and Methodological Support of StabMed 2.0 Stabilometric Complex), Taganrog: OKB Ritm, 2004.

  4. Albanese, A., EFNS guidelines on diagnosis and treatment of primary dystonias, J. Eur. J. Neurol., 2011, vol. 18, pp. 5–18.

    Article  CAS  Google Scholar 

  5. Albanese, A., Bhatia, K., and Bressman, S.B., Phenomenology and classification of dystonia: a consensus update, Mov. Disord., 2013, vol. 28, pp. 863–873.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Azher, S.N. and Jankovic, J., Camptocormia: pathogenesis, classification, and response to therapy, Neurology, 2005, vol. 65, pp. 355–359.

    Article  PubMed  Google Scholar 

  7. Bloch, F., Houeto, J.L., Tezenas du Montcel, S., et al., Parkinson’s disease with camptocormia, J. Neurol. Neurosurg. Psychiatry, 2006, vol. 77, pp. 1223–1228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Delcey, V., Hachulla, E., Michon-Pasturel, U., et al., Camptocormia: a sign of axial myopathy. Report of 7 cases, Rev. Med. Interne., 2002, vol. 23, pp. 144–154.

    Article  CAS  PubMed  Google Scholar 

  9. Dressier, D., Botulinum Toxin Therapy, Stuttgart: Thieme-Verlag, 2000.

    Google Scholar 

  10. Fietzek, U.M., Schroeteler, F.E., and Ceballos-Baumann, A.O., Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin, Mov. Disord., 2009, vol. 24, pp. 2027–2028.

    Article  PubMed  Google Scholar 

  11. Finsterer, J. and Strobl, W., Presentation, etiology, diagnosis, and management of camptocormia, Eur. Neurol., 2010, vol. 64, pp. 1–8.

    Article  PubMed  Google Scholar 

  12. Gómez-Puerta, J.A., Peris, P., Grau, J.M., et al., Camptocormia as a clinical manifestation of mitochondrial myopathy, Clin. Rheumatol., 2007, vol. 26, pp. 1017–1019.

    Article  PubMed  Google Scholar 

  13. Grigoriu, A.I., Dinomais, M., Rémy-Néris, O., et al., Impact of injection guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review, Arch. Phys. Med. Rehabil., 2015, vol. 96, pp. 2067–2078.

    Article  PubMed  Google Scholar 

  14. Hachulla, E., Dermatomyositis and polymyositis: clinical aspects and treatment, Ann. Med. Interne., 2001, vol. 152, pp. 455–464.

    CAS  Google Scholar 

  15. Illarioshkin, S.N., Markova, E.D., Slominsky, P.A., et al., The GTP cyclohydrolase I gene in Russian families with dopa-responsive dystonia, Arch. Neurol., 1998, vol. 55, pp. 789–792.

    Article  CAS  PubMed  Google Scholar 

  16. Jankovic, J., Disease-oriented approach to botulinum toxin use, Toxicon, 2009, vol. 54, pp. 614–623.

    Article  CAS  PubMed  Google Scholar 

  17. Karbowski, K., The old and the new camptocormia, Spine, 1999, vol. 24, pp. 1494–1498.

    Article  CAS  PubMed  Google Scholar 

  18. Kim, J.M., Song, E.J., Seo, J.S., et al., Polymyositis-like syndrome caused by hypothyroidism, presenting as camptocormia, Rheumatol. Int., 2009, vol. 29, pp. 339–342.

    Article  PubMed  Google Scholar 

  19. Kumar, H. and Jog, M., Peripheral trauma induced dystonia or post-traumatic syndrome? Can. J. Neurol. Sci., 2011, vol. 38, pp. 22–29.

    Article  PubMed  Google Scholar 

  20. Lepoutre, A.C., Devos, D., Blanchard-Dauphin, A., et al., A specific clinical pattern of camptocormia in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 2006, vol. 77, pp. 1229–1234.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Loseth, S., Voermans, N.C., Torbergsen, T., et al., A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene, J. Neurol., 2013, vol. 260, pp. 1504–1510.

    Article  CAS  PubMed  Google Scholar 

  22. Lyons, M.K., Deep brain stimulation: current and future clinical applications, Mayo Clin. Proc., 2011, vol. 86, pp. 662–672.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ma, H., McEvoy, K.M., and Milone, M., Sporadic inclusion body myositis presenting with severe camptocormia, J. Clin. Neurosci., 2013, vol. 20, pp. 1628–1629.

    Article  PubMed  Google Scholar 

  24. Melamed, E. and Djaldetti, R., Camptocormia in Parkinson’s disease, J. Neurol., 2006, vol. 253, pp. 14–16.

    Article  Google Scholar 

  25. Mezaki, T., Clinical characteristics and treatment of dystonia, Rinsho Shinkeigaku, 2011, vol. 51, pp. 465–470.

    Article  PubMed  Google Scholar 

  26. Ohana, M., Durand, M.C., Marty, C., et al., Wholebody muscle MRI to detect myopathies in non-extrapyramidal bent spine syndrome, Skeletal Radiol., 2014, vol. 43, pp. 1113–1122.

    Article  PubMed  Google Scholar 

  27. Reichel, G., Kirchhöfer, U., and Stenner, A., Camptocormia—segmental dystonia. Proposal of a new definition for an old disease, Nervenarzt, 2001, vol. 72, pp. 281–285.

    Article  CAS  PubMed  Google Scholar 

  28. Skidmore, F., Anderson, K., Fram, D., et al., Psychogenic camptocormia, Mov. Disord., 2007, vol. 22, pp. 1974–1975.

    Article  PubMed  Google Scholar 

  29. Srivanitchapoom, P. and Hallett, M.J., Camptocormia in Parkinson’s disease: definition, epidemiology, pathogenesis and treatment modalities, Neurol. Neurosurg. Psychiatry, 2015, vol. 87, pp. 75–85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Republican Scientific and Practical Center of Neurology and Neurosurgery of the Ministry of Health of Belarus, Minsk, Belarus

    S. A. Likhachev, T. N. Chernukha, G. V. Zabrodets, O. V. Gleb, V. V. Alekseevets & V. S. Terekhov

Authors
  1. S. A. Likhachev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. N. Chernukha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. V. Zabrodets
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. V. Gleb
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. V. Alekseevets
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. S. Terekhov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. N. Chernukha.

Additional information

Original Russian Text © S.A. Likhachev, T.N. Chernukha, G.V. Zabrodets, O.V. Gleb, V.V. Alekseevets, V.S. Terekhov, 2016, published in Annaly Klinicheskoi i Eksperimental’noi Nevrologii, 2016, Vol. 10, No. 2, pp. 17–22.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Likhachev, S.A., Chernukha, T.N., Zabrodets, G.V. et al. Dystonic Camptocormia: Clinical Presentation, Diagnosis, and Treatment Results. Hum Physiol 43, 870–874 (2017). https://doi.org/10.1134/S0362119717080060

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0362119717080060

Keywords

Search

Navigation